Investigation & Intelligence Feeds
State Attorneys General Announce AI Task Force
This week the Attorney General Alliance released a statement on the creation of an Artificial Intelligence Task Force in a “bipartisan...
IP Hot Topic: Is This Clear Enough? A Caution Against Claiming Transparency but Excluding Translucency From a Design Patent’s Scope
A U.S. design patent protects how something looks, as opposed to how it works. An applicant conveys that look primarily using drawings....
USC Sues Google for Infringing Mapping Patents: Just Another Form of Anticompetitive Conduct
University of Southern California (USC) sued Google LLC in the Western District of Texas, Austin Division, last month, alleging infring...
Inside HPE Europe 2025 | European healthcare investment in 2026: Outpatient services, optimisation, and optimism
As macro trends such as population growth, ageing demographics, and co-morbidities place increasing pressure on healthcare systems, inv...
Securing Strategic Sectors: Insights from McDermott’s Defense & Essential Infrastructure Roundtable
In October 2025, McDermott Will & Schulte hosted its Defense & Essential Infrastructure Roundtable, convening leading voices fr...
Trump Administration Executive Order Tracker – November 2025
Below is a tracker of healthcare-related executive orders (EOs) issued by the Trump administration, including overviews of each EO and ...
Your Law Firm Will Die If Leadership Doesn’t Go All In On AI
The McKinsey Global Survey on AI just confirmed what some of us have been screaming into the void for years. Most organizations are pla...
Data Privacy: Looking Behind the Curtain
While it’s common for companies to think that simply having a data privacy policy is enough to meet privacy law requirements, a strong ...
Supply Chain Technology and Vessel Tracking: A Better Approach to Barge Logistics
Inland barge transportation is a cornerstone of the U.S. energy supply chain, facilitating the movement of crude oil, refined products,...
PTAB Denies Institution of Two Sarepta IPRs Related to Elevidys®
On November 6, 2025, the Patent Trial and Appeal Board (“Board”) issued decisions denying institution of Sarepta Therapeutics’ IPR2025-...